Literature DB >> 10829984

Multi drug resistant tuberculosis.

K Chopra1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 10829984     DOI： 10.1007/bf02845239

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  9 in total

1.  Drug-resistant tuberculosis.

Authors:  D E Snider; G M Cauthen; L S Farer; G D Kelly; J O Kilburn; R C Good; S W Dooley
Journal:  Am Rev Respir Dis       Date:  1991-09

2.  Multidrug-resistant tuberculosis.

Authors:  S W Dooley; W R Jarvis; W J Martone; D E Snider
Journal:  Ann Intern Med       Date:  1992-08-01       Impact factor: 25.391

3.  Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis.

Authors:  F G Winder; P B Collins
Journal:  J Gen Microbiol       Date:  1970-09

4.  Mechanisms of drug resistance in Mycobacterium tuberculosis.

Authors:  S T Cole
Journal:  Immunobiology       Date:  1994-10       Impact factor: 3.144

Review 5.  Treatment of multidrug-resistant tuberculosis.

Authors:  M D Iseman
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245

6.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.

Authors:  M C Raviglione; D E Snider; A Kochi
Journal:  JAMA       Date:  1995-01-18       Impact factor: 56.272

7.  The emergence of drug-resistant tuberculosis in New York City.

Authors:  T R Frieden; T Sterling; A Pablos-Mendez; J O Kilburn; G M Cauthen; S W Dooley
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

8.  Isolation and characterization of isoniazid-resistant mutants of Mycobacterium smegmatis and M. aurum.

Authors:  B Heym; S T Cole
Journal:  Res Microbiol       Date:  1992-09       Impact factor: 3.992

9.  Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.

Authors:  M Goble; M D Iseman; L A Madsen; D Waite; L Ackerson; C R Horsburgh
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245
  9 in total
  2 in total

1.  ACCase 6 is the essential acetyl-CoA carboxylase involved in fatty acid and mycolic acid biosynthesis in mycobacteria.

Authors:  Daniel G Kurth; Gabriela M Gago; Agustina de la Iglesia; Bernardo Bazet Lyonnet; Ting-Wan Lin; Héctor R Morbidoni; Shiou-Chuan Tsai; Hugo Gramajo
Journal:  Microbiology (Reading)       Date:  2009-05-07       Impact factor: 2.777

2.  Structure-based inhibitor design of AccD5, an essential acyl-CoA carboxylase carboxyltransferase domain of Mycobacterium tuberculosis.

Authors:  Ting-Wan Lin; Melrose M Melgar; Daniel Kurth; S Joshua Swamidass; John Purdon; Teresa Tseng; Gabriela Gago; Pierre Baldi; Hugo Gramajo; Shiou-Chuan Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.